Navigation Links
Aspira Scientific Introduces Xeno-free rHSA Product at World Stem Cell Summit
Date:12/5/2013

SAN FRANCISCO, Dec. 5, 2013 /PRNewswire/ -- Aspira Scientific, Inc., a research and development solutions provider for the chemical and biological sectors, today announces the official launch of its recombinant Human Serum Albumin (rHSA) product. Aspira Scientific's highly pure, cost-effective rHSA is produced from a proprietary expression technology platform, originating from rice grains (Oryza sativa) and is more than 99 percent devoid of any animal, human, or micro-organism derived components ("xeno-free"). To learn more about rHSA, visit www.aspirasci.com/rhsa.

(Logo: http://photos.prnewswire.com/prnh/20131205/AQ28432LOGO)

Produced by the innovative plant-based protein technology pioneered by Dr. Daichang Yang of Healthgen Biotechnology Co., Ltd., rHSA has the same application fields as plasma-derived Human Serum Albumin (pHSA), but offers a higher purity, more consistent, xeno-free replacement that can be manufactured to scale. Aspira Scientific's rHSA is made more cost-effectively and safely than other rHSA products, avoiding immunogenicity concerns of rHSA produced in yeast-based expression systems.

"We are proud to collaborate with our strategic manufacturing partner, Healthgen Biotechnology, to offer this ultra-pure, yet highly affordable rHSA for the research market," said Dr. John Chan, CEO, Aspira Scientific. "Our rHSA will fuel innovations in quality-demanding applications such as stem cell therapy, targeted drug delivery, and medical device coating; as well as decrease costs dramatically in high-volume applications such as cell culture media development."

Aspira Scientific's rHSA is manufactured in an ISO 9001 certified facility with rigorous quality control and superior batch-to-batch consistency. The product complies with global regulatory recommendations for non-animal derived components for pharmaceutical related research and development and is available in small-to-large scale commercial quantities.

About Aspira Scientific
Aspira Scientific empowers scientists to achieve their aspirations in chemical and biological research and development by reducing the costs of basic and applied research. The company leverages a global innovation ecosystem to offer a wide array of next-generation enabling research tools. For organizations with developmental programs and commercial intent, Aspira Scientific provides user-driven services via a "Collaborate Locally. Commercialize Globally."™ model to afford exceptional value in terms of innovation, quality and IP assurance, and cost efficiency. For more information, visit www.aspirasci.com.

MEDIA CONTACT:
Dianne Needham
Marketing Communications
dianne.needham@aspirasci.com
408.761.3738


'/>"/>
SOURCE Aspira Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Hajarian New Surgical Retractor/Aspirator May Revoultionize Surgical Retractors
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
4. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
5. Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
6. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
7. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
8. Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent
9. Generex Augments Antigen Express Scientific Advisory Board
10. Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
11. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):